These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16393909)

  • 21. Inhibition of some human neutrophil functions by the cyclooxygenase inhibitor ketorolac tromethamine.
    Hyers TM; Tricomi SM; Liao JJ
    J Leukoc Biol; 1992 May; 51(5):490-5. PubMed ID: 1318350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanistic evaluation of the effect of sintering on Compritol 888 ATO matrices.
    Rao M; Ranpise A; Borate S; Thanki K
    AAPS PharmSciTech; 2009; 10(2):355-60. PubMed ID: 19333763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery.
    Morsi N; Ghorab D; Refai H; Teba H
    Int J Pharm; 2016 Jun; 506(1-2):57-67. PubMed ID: 27091293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and in vitro evaluation of controlled release hydrophilic matrix tablets of ketorolac tromethamine using factorial design.
    Genç L; Jalvand E
    Drug Dev Ind Pharm; 2008 Aug; 34(8):903-10. PubMed ID: 18686094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eudragit RL100 Based Moxifloxacin Hydrochloride and Ketorolac Tromethamine Combination Nanoparticulate System for Ocular Drug Delivery.
    Salvi V; Pawar P
    Pharm Nanotechnol; 2020; 8(2):133-147. PubMed ID: 32167436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and in vitro evaluations of gelatin A microspheres of ketorolac tromethamine for intranasal administration.
    Sankar C; Mishra B
    Acta Pharm; 2003 Jun; 53(2):101-10. PubMed ID: 14764244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation, characterization, and in vitro release study of albendazole-encapsulated nanosize liposomes.
    Panwar P; Pandey B; Lakhera PC; Singh KP
    Int J Nanomedicine; 2010 Mar; 5():101-8. PubMed ID: 20309396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential of cyclodextrin complexation and liposomes in topical delivery of ketorolac: in vitro and in vivo evaluation.
    Nagarsenker MS; Amin L; Date AA
    AAPS PharmSciTech; 2008; 9(4):1165-70. PubMed ID: 19016331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of preservative, antioxidant and viscolizing agents on in vitro transcorneal permeation of ketorolac tromethamine.
    Malhotra M; Majumdar DK
    Indian J Exp Biol; 2002 May; 40(5):555-9. PubMed ID: 12622201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development, evaluation and pharmacokinetics of time-dependent ketorolac tromethamine tablets.
    Vemula SK; Veerareddy PR
    Expert Opin Drug Deliv; 2013 Jan; 10(1):33-45. PubMed ID: 23199134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
    Shaji J; Menon I
    Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of a high-performance thin-layer chromatographic method, with densitometry, for quantitative analysis of ketorolac tromethamine in human plasma.
    López-Bojórquez E; Castañeda-Hernández G; González-de la Parra M; Namur S
    J AOAC Int; 2008; 91(5):1191-5. PubMed ID: 18980140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ketorolac tromethamine formulations: an overview.
    Sinha VR; Kumar RV; Singh G
    Expert Opin Drug Deliv; 2009 Sep; 6(9):961-75. PubMed ID: 19663721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Approaches for improving the stability of ketorolac in powder blends.
    Brandl M; Magill A; Rudraraju V; Gordon MS
    J Pharm Sci; 1995 Oct; 84(10):1151-3. PubMed ID: 8801326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microencapsulation of ketorolac tromethamine by means of a coacervation-phase separation technique induced by the addition of non-solvent.
    Genç L; Demirel M; Güler E; Hegazy N
    J Microencapsul; 1998; 15(1):45-53. PubMed ID: 9463806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developing Transdermal Applications of Ketorolac Tromethamine Entrapped in Stimuli Sensitive Block Copolymer Hydrogels.
    Mallandrich M; Fernández-Campos F; Clares B; Halbaut L; Alonso C; Coderch L; Garduño-Ramírez ML; Andrade B; Del Pozo A; Lane ME; Calpena AC
    Pharm Res; 2017 Aug; 34(8):1728-1740. PubMed ID: 28540502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cationic liposomes for gene transfection.
    Ruozi B; Forni F; Battini R; Vandelli MA
    J Drug Target; 2003 Aug; 11(7):407-14. PubMed ID: 15203929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and properties of poly(vinyl alcohol)-stabilized liposomes.
    Mu X; Zhong Z
    Int J Pharm; 2006 Aug; 318(1-2):55-61. PubMed ID: 16624507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement in bioavailability of ketorolac tromethamine via intranasal in situ hydrogel based on poloxamer 407 and carrageenan.
    Li C; Li C; Liu Z; Li Q; Yan X; Liu Y; Lu W
    Int J Pharm; 2014 Oct; 474(1-2):123-33. PubMed ID: 25138250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The morphine sparing effect of ketorolac tromethamine. A study of a new, parenteral non-steroidal anti-inflammatory agent after abdominal surgery.
    Gillies GW; Kenny GN; Bullingham RE; McArdle CS
    Anaesthesia; 1987 Jul; 42(7):727-31. PubMed ID: 3307518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.